Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income - TrustIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest Expense - DebtInterest Expense - DepositsInterest Expense - OthersInterest ExpensesInterest Income - Debt SecuritiesInterest Income - NetInterest Income - TotalInterest income - LoansInvestment Banking IncomeInvestment Gain (Loss)Mortgage BankingNet Income towards Common StockholdersNon-Interest IncomeOperating ExpensesOther Non-Interest IncomeOther Operating ExpensesOther interest incomePreferred Dividend PaymentsProfit After TaxProvisionsResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Huntington Bancshares (HBANM) Research & Development (2021 - 2025)

Huntington Bancshares (HBANM) has disclosed Research & Development for 5 consecutive years, with $222.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 32.93% to $222.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $772.0 million, a 16.09% increase, with the full-year FY2025 number at $772.0 million, up 16.09% from a year prior.
  • Research & Development was $222.0 million for Q4 2025 at Huntington Bancshares, up from $198.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $304.0 million in Q3 2021 to a low of $115.0 million in Q1 2021.
  • A 5-year average of $175.1 million and a median of $165.0 million in 2022 define the central range for Research & Development.
  • Biggest YoY gain for Research & Development was 43.48% in 2022; the steepest drop was 52.3% in 2022.
  • Huntington Bancshares' Research & Development stood at $269.0 million in 2021, then tumbled by 45.35% to $147.0 million in 2022, then rose by 6.8% to $157.0 million in 2023, then increased by 6.37% to $167.0 million in 2024, then soared by 32.93% to $222.0 million in 2025.
  • Per Business Quant, the three most recent readings for HBANM's Research & Development are $222.0 million (Q4 2025), $198.0 million (Q3 2025), and $182.0 million (Q2 2025).